Arthritis is often associated with older adults, but children can develop it, too. Known as juvenile arthritis, this group of conditions can affect a child’s joints, immune system, and overall health.

A global comparison of psoriatic arthritis guidelines reveals differences in treatment sequencing and domain-specific strategies, with all emphasizing treat-to-target goals and comorbidity management.

Jack Troyano mostly lives like a typical boy. But the frequent shots and weekly infusions he gets for juvenile arthritis tell a different story.

Treatment with tofacitinib led to improved disease control and physical function among patients with juvenile idiopathic arthritis.

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...

Joni Kazantzis didn't think her psoriasis would turn into psoriatic arthritis. But the new diagnosis taught her—and her daughters—some important life lessons.

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, creating a condition that challenges patients and clinicians alike.

Elizabeth Medeiros is a freelance writer and blogger. She hopes to inspire those living with chronic pain by sharing her experiences with juvenile-onset psoriatic arthritis and offering practical ...

Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.

A study identifies clinical characteristics and predictors of psoriatic arthritis in patients with juvenile idiopathic arthritis (JIA) 18 years after disease onset, revealing key features like ...

Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.